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Background: The purpose of this study is to evaluate the retinal and choroidal thickness of the macular
region in patients with unilateral relentless placoid chorioretinitis (RPC) and macular involvement. Patients
diagnosed with RPC affecting only one eye underwent a comprehensive ophthalmologic examination
including best-corrected visual acuity (BCVA), axial length (AL) measurement, slit-lamp examination, and
color fundus and autofluorescence photography. The macular region was scanned by swept-source optical
coherence tomography in the 1,050-nm wavelength. Automated segmentations of the retina and the choroid
were used to obtain the corresponding thickness values.
Results: A total number of three patients (two men and one woman; age range 17 to 62 years) were
included. Eyes with clinically evident RPC had a mean AL of 24.62 ± 0.11 mm, whereas in the clinically
healthy fellow eyes, the mean AL was 24.65 ± 0.03 (p = 0.70). The mean BCVA was 0.93 ± 0.16 in eyes with
RPC, and 1.0 in all the fellow eyes (p = 0.70). Slit-lamp examination did not reveal any sign of vitreous
inflammation in any cases. The mean macular retinal thickness was 288.10 ± 10.22 μm in eyes with RPC,
and 300.30 ± 7.17 μm in the healthy fellow eyes (p = 0.20). The mean central choroidal thickness was 260.70
± 140.60 μm in eyes with RPC, and 262.30 ± 123.10 μm in the fellow eyes (p = 0.99). The mean macular
choroidal thickness was 248.60 ± 128.40 and 255.10 ± 123.60 μm, respectively (p = 0.99).
Conclusions: The pathogenesis of RPC remains unknown. No changes in the retinal and choroidal thickness
were observed in the macular area of eyes diagnosed with RPC with macular involvement compared with the
asymptomatic healthy fellow eyes. Further prospective studies are warranted in order to investigate the role
of the choroid in cases of RPC.
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Figure 1 Modified ETDRS grid (6 × 6 mm) overlapped to the
fundus color photography. This was done in order to analyze the
retinal and choroidal thickness. The grid was subdivided in nine
independent sectors: a central sector (C) within 500 μm from the
fovea, four inner sectors within 500 to 1,500 μm from the fovea (iSUP,
iTEM, iINF, iNAS), and four outer sectors within 1,500 to 3,000 μm from
the fovea (oSUP, oTEM, oINF, oNAS).
Figure 2 Patient 1: a 62-year-old woman diagnosed with unilateral re
fundus and autofluorescence images (A-B) evidence multiple coalescent at
retina. The retinal (C) and choroidal (D) thickness maps show normal meas
centered in the fovea (E) demonstrates atrophic changes in the RPE in the te
retina. The choroid shows no tomographic alteration in the macular area, wh
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Relentless placoid chorioretinitis (RPC), also known as
ampiginous choroiditis, was first described by Jones et al.
as a particular type of posterior uveitis that shared clinical
and angiographic characteristics with acute posterior
multifocal placoid pigment epitheliopathy (APMPPE) and
serpiginous choroiditis. However, it typically exhibits a
prolonged clinical course, with recurrences of the inflam-
mation after months to years following the onset [1-3].
The scattered distribution of the multiple, plaque-like,
creamy coalescent lesions, affecting simultaneously the
posterior pole and the midperipheral retina, usually leads
to poor visual outcomes [1].
The etiopathogenesis of RPC remains unknown, but
both fluorescein and indocyanine green angiographic
findings evidence involvement of the choroid altogether
with the typical retinal changes [1]. The analysis of the
choroidal morphologic and morphometric features
has significantly improved with the development of
high-penetrance optical coherence tomography (OCT)lentless placoid chorioretinitis affecting her left eye. The color
rophic lesions affecting the posterior pole and the periphery of the
ures. The swept-source horizontal optical coherence tomography scan
mporal macular region associated with areas of disruption of the outer
ereas an indirect hyper-reflectivity is seen in the areas of RPE atrophy.
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swept-source (SS) laser technology. The SS-OCT is char-
acterized by a light source with a longer wavelength of
1,050 nm. This technical change allows deeper penetration
through the ocular tissue, thus obtaining a three-
dimensional (3D) high-contrast image of the retina and
the choroid [6,7]. This system has a scanning speed of
100,000 A-scans per second and a scan window depth of
2.6 mm with an axial resolution of 8 mm and a transverse
resolution of 20 mm in tissue [8]. In the present study, we
evaluated the choroidal thickness of the macular area in
patients with unilateral RPC and macular involvement.
Methods
This observational retrospective study evaluated patients
diagnosed with macular involvement due to unilateral
RPC by a single physician (RGP) according to the pre-
vious reports on this disease [1-3]. The present study
was conducted in accordance with the principles of the
Declaration of Helsinki and in compliance with the LaFigure 3 Patient 2: a 50-year-old man diagnosed with unilateral relen
fundus and autofluorescence images (A-B) demonstrate typical atrophic le
and far retinal periphery. The retinal (C) and choroidal (D) thickness maps e
optical coherence tomography scan centered in the fovea (E) shows a tem
temporal macular region and a diffuse choroidal thinning.Fe University and Polytechnic Hospital review board and
informed consent regulations.
We performed a comprehensive ophthalmic exa-
mination including best-corrected visual acuity (BCVA)
using standard early treatment of diabetic retinopathy
study (ETDRS) charts (decimal scale), axial length (AL)
measurement (IOLMaster 500, Carl Zeiss Meditec, Inc.,
Dublin, CA, USA), slit-lamp examination, and color fundus
and autofluorescence photographs (Visupac, Carl Zeiss
Meditec Inc.). The macular region of all patients was
scanned with SS-OCT (DRI OCT-1 Atlantis, Topcon,
Tokyo, Japan) at a 1,050-nm wavelength with a 3D
raster scan protocol. The SS-OCT 3D scan modality
produces a retinal and choroidal thickness map of the
macular area (12 × 9 mm) after an automated segmenta-
tion of the retina and the choroid. The retinal and chor-
oidal thickness maps were overlap to the modified ETDRS
grid (6 × 6 mm) to study the different mean values of
each sector (Figure 1). The mean thickness of each sec-
tor was automatically measured within 500 μm from thetless placoid chorioretinitis affecting his right eye. The color
sions involving the macula and also distributed widespread in the mid
vidence normal topographic measures. The swept-source horizontal
poral window defect consistent with the atrophy of the RPE in the
Figure 4 Patient 3: a 17-year-old boy diagnosed with unilateral relentless placoid chorioretinitis affecting his left eye. The color fundus
and autofluorescence images (A-B) demonstrate multiple lesions widespread distributed throughout the retina, predominantly in the nasal
region and involving the macula. The retinal (C) and choroidal (D) thickness maps evidence normal topographic measures. The swept-source
horizontal optical coherence tomography scan centered in the fovea (E) shows minimal RPE changes with a normal choroidal tissue.
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from the center of the fovea in four juxtafoveal or inner
sectors (superior, inferior, nasal, and temporal), and 1,500
to 3,000 μm from the center of the fovea in four extra-
foveal or outer sectors (superior, inferior, temporal,
and nasal).
All the data were processed and a comparison between
the data of the affected eye and the fellow healthy eye
was performed. Statistical analysis was performed using
Statistical Package for Social Sciences v.20.0 (IBM Corp.,
Armonk, NY, USA).Table 1 Mean retinal thickness values per sector
Sector Retina
Study eyes Fellow eyes p value
Central 257.33 ± 31.53 269.33 ± 19.76 0.827
Juxtafoveal nasal 310.00 ± 23.58 316.33 ± 17.95 0.658
Juxtafoveal inferior 283.67 ± 24.13 289.30 ± 4.62 0.825
Juxtafoveal temporal 310.67 ± 10.69 327.70 ± 9.50 0.127
Juxtafoveal superior 266.00 ± 8.88 271.70 ± 24.79 0.827
Extrafoveal nasal 308.00 ± 11.27 324.00 ± 5.00 0.127
Extrafoveal inferior 270.33 ± 15.04 289.99 ± 32.05 0.275
Extrafoveal temporal 316.33 ± 10.02 328.70 ± 6.66 0.127
Extrafoveal superior 270.33 ± 6.11 287.00 ± 18.52 0.127
Mean 288.07 ± 10.22 300.30 ± 7.17 0.127Results
Three patients (two men aged 50 and 17 years and one
woman aged 62 years) diagnosed with RPC and macular
involvement were included (Figures 2, 3, and 4). The
time from the onset of visual symptoms related to RPC
was 56, 8, and 4 months for each case, respectively. Eyes
with clinically evident RPC had a mean AL of 24.62 ±
0.11 mm, whereas in the clinically healthy fellow eyes,
AL was 24.65 ± 0.03 mm (p = 0.70). The mean BCVA
was 0.93 ± 0.16 (range 0.80 to 1.0) in the eyes with RPC,
and 1.0 in all the fellow eyes (p = 0.70). The slit-lampTable 2 Mean choroidal thickness values per sector
Sector Choroid
Study eyes Fellow eyes p value
Central 260.67 ± 140.61 262.33 ± 123.09 0.827
Juxtafoveal nasal 260.68 ± 137.70 247.33 ± 142.42 0.658
Juxtafoveal inferior 260.69 ± 76.36 198.00 ± 122.39 0.827
Juxtafoveal temporal 260.70 ± 155.02 256.33 ± 134.93 0.827
Juxtafoveal superior 260.71 ± 163.02 238.67 ± 135.55 0.827
Extrafoveal nasal 260.72 ± 146.32 271.67 ± 117.46 0.827
Extrafoveal inferior 260.73 ± 132.20 250.00 ± 113.22 0.513
Extrafoveal temporal 260.74 ± 124.94 287.67 ± 125.64 0.827
Extrafoveal superior 260.75 ± 100.37 283.67 ± 129.08 0.827
Mean 260.76 ± 128.44 255.07 ± 123.62 0.827
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ior chamber inflammatory cells in all cases. All patients
had been treated with oral steroids in a tapering regimen
starting from a maximum dose of 90 mg per day (1 mg/
kg/day). By the time of the SS-OCT examination, none
of them was under steroid therapy (minimum 1 month
after steroid cessation).
Quantitative analysis of the retina
The mean automatically measured retinal thickness of
the macular area was 288.10 ± 10.22 μm in eyes with
RPC and 300.30 ± 7.17 μm in the healthy fellow eyes;
no statistically significant differences were evidenced
(p = 0.20). The mean automatically measured retinal
thickness in the central sector of the ETDRS grid (within
500 μm from the center of the fovea) was 257.33 ± 31.53
μm in eyes with RPC, and 269.33 ± 19.75 μm in the
healthy fellow eyes; no statistically significant differences
were observed (p = 0.99). The mean retinal thicknesses
of the nasal, inferior, temporal, and superior sectors
automatically measured in the juxtafoveal area (500 to
1,500 μm from the center of the fovea) and in the extra-
foveal area (1,500 to 3,000 μm from the center of the
fovea) are summarized in the Table 1.
Quantitative analysis of the choroid
The mean automatically measured choroidal thickness
of the entire macular region was 248.60 ± 128.40 μm in
eyes with RPC, and 255.10 ± 123.60 μm in the healthy
fellow eyes; no statistically significant differences were
observed (p = 0.99). The mean automatically measured
choroidal thickness in the central sector of the ETDRS
grid (within 500 μm from the center of the fovea) was
260.70 ± 140.60 μm in the study eyes, and 262.30 ±
123.10 μm in the healthy fellow eyes; no statistically sig-
nificant differences were evidenced (p = 0.99). The mean
automatically measured choroidal thickness in the juxta-
foveal sectors (500 to 1,500 μm from the center of the
fovea) and extrafoveal sectors (1,500 to 3,000 μm from
the center of the fovea) showed no significant differences
between the affected eyes and the healthy fellow eyes as
reported in the Table 2.
Discussion
The differential diagnosis of RPC includes mainly
APMPPE and serpiginous choroiditis. These diseases
share similar clinical and angiographic characteristics,
with creamy lesions that exhibit early hypofluores-
cence in the fluorescein angiography with later stai-
ning [1]. The different clinical course and the atypical
distribution of the lesions in patients with RPC may
assist its diagnosis, although some cases may need a
long-term follow-up to be able to differentiate them.The angiographic characteristics in patients with acute
RPC reveal a presumed choroidal involvement, which rep-
resent a common finding in cases of posterior uveitis.
Changes in the choroidal thickness have been reported in
many inflammatory diseases as Vogt-Koyanagi-Harada
disease [8], Behçet uveitis [9] or posterior scleritis [10]. To
the best of our knowledge, there are no reports in the lit-
erature regarding the influence of RPC, APMPPE, or ser-
piginous choroiditis in the choroidal tissue.
Conclusions
We studied the retinal and choroidal thickness of the
macula in cases of unilateral RPC with macular involve-
ment in a quiescent stage. Our results did not evidence
any difference in the retinal or choroidal thickness in the
macular area when comparing the affected eye with the
fellow healthy eye. We hypothesized that this characteris-
tic may help in the differential diagnosis with serpiginous
choroiditis, since cases of serpiginous choroiditis may lead
to severe atrophic legacy not only in the retina but also in
the choroid. This relative sparing of the choroid in RPC
may be related to the degree of the inflammatory reaction
on the tissue.
The limitations of our study include the short number of
patients and follow-up. There is also a lack of reports re-
garding the choroidal thickness in cases of posterior uve-
itis. Further studies are warranted in order to confirm the
sparing of the choroidal thickness in cases of RPC. These
data might be useful in the differentiation of plaque-like
white dot syndromes as RPC, APMPPE, and serpiginous
choroiditis.
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